» Articles » PMID: 21646396

Interaction of the Gp120 V1V2 Loop with a Neighboring Gp120 Unit Shields the HIV Envelope Trimer Against Cross-neutralizing Antibodies

Overview
Journal J Exp Med
Date 2011 Jun 8
PMID 21646396
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

The HIV-1 envelope trimer adopts a quaternary conformation that effectively shields neutralization-sensitive domains and thus represents a major obstacle for natural and vaccine-elicited antibody responses. By using a structure-function analysis based on a specifically devised mathematical model, we demonstrate in this study that protection from neutralization is enforced by intersubunit contact between the variable loops 1 and 2 (V1V2) and domains of neighboring gp120 subunits in the trimer encompassing the V3 loop. Our data are consistent with an interaction of the V1V2 and V3 loop at the spike apex as proposed by cryoelectron tomography experiments. By defining the orientation of the V1V2 loop within the trimer toward the neighboring gp120 subunit's V3 loop, our data close an important gap in the understanding of the architecture of the trimeric spike. Knowledge on how the V1V2 barrier functions in the context of the trimer to mask conserved epitopes on gp120 may aid future vaccine design.

Citing Articles

Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.

Foulkes C, Friedrich N, Ivan B, Stiegeler E, Magnus C, Schmidt D PLoS Pathog. 2025; 21(1):e1012825.

PMID: 39836706 PMC: 11774494. DOI: 10.1371/journal.ppat.1012825.


Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.

Zacharopoulou P, Lee M, Oliveira T, Thornhill J, Robinson N, Brown H Front Immunol. 2024; 15:1352123.

PMID: 38562938 PMC: 10982389. DOI: 10.3389/fimmu.2024.1352123.


Assessing immunogenicity barriers of the HIV-1 envelope trimer.

Maliqi L, Friedrich N, Glogl M, Schmutz S, Schmidt D, Rusert P NPJ Vaccines. 2023; 8(1):148.

PMID: 37777519 PMC: 10542815. DOI: 10.1038/s41541-023-00746-3.


Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization.

Glogl M, Friedrich N, Cerutti G, Lemmin T, Kwon Y, Gorman J Nat Struct Mol Biol. 2023; 30(9):1323-1336.

PMID: 37605043 PMC: 10497408. DOI: 10.1038/s41594-023-01062-z.


SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env.

Kirschman J, Marin M, Chen Y, Chen J, Herschhorn A, Smith 3rd A Viruses. 2022; 14(7).

PMID: 35891369 PMC: 9323560. DOI: 10.3390/v14071388.


References
1.
Cicala C, Martinelli E, McNally J, Goode D, Gopaul R, Hiatt J . The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A. 2009; 106(49):20877-82. PMC: 2780317. DOI: 10.1073/pnas.0911796106. View

2.
Xiang S, Finzi A, Pacheco B, Alexander K, Yuan W, Rizzuto C . A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol. 2010; 84(7):3147-61. PMC: 2838131. DOI: 10.1128/JVI.02587-09. View

3.
Pancera M, Majeed S, Ban Y, Chen L, Huang C, Kong L . Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc Natl Acad Sci U S A. 2010; 107(3):1166-71. PMC: 2824281. DOI: 10.1073/pnas.0911004107. View

4.
Krachmarov C, Honnen W, Kayman S, Gorny M, Zolla-Pazner S, Pinter A . Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. J Virol. 2006; 80(14):7127-35. PMC: 1489036. DOI: 10.1128/JVI.02619-05. View

5.
Gorny M, Stamatatos L, Volsky B, Revesz K, Williams C, Wang X . Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J Virol. 2005; 79(8):5232-7. PMC: 1069558. DOI: 10.1128/JVI.79.8.5232-5237.2005. View